ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | - | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr | ₹3.23 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ORCHID PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | - |
Mar2023 | ₹3.23 Cr |
Mar2022 | ₹3.23 Cr |
Mar2021 | ₹3.23 Cr |
Mar2020 | ₹3.23 Cr |
How is Deferred Tax Assets / Liabilities of ORCHID PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | -100.00 | |
Mar2023 | ₹3.23 Cr | 0.00 | |
Mar2022 | ₹3.23 Cr | 0.00 | |
Mar2021 | ₹3.23 Cr | 0.00 | |
Mar2020 | ₹3.23 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹3,797.7 Cr | 3.6% | 6.7% | -34.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 3.6% |
6.7% |
-34.5% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses